Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

TELA Bio (TELA) EBT Margin (2018 - 2025)

Historic EBT Margin for Bio (TELA) over the last 8 years, with Q3 2025 value amounting to 41.58%.

  • Bio's EBT Margin rose 131300.0% to 41.58% in Q3 2025 from the same period last year, while for Sep 2025 it was 50.69%, marking a year-over-year increase of 108700.0%. This contributed to the annual value of 54.81% for FY2024, which is 250200.0% up from last year.
  • As of Q3 2025, Bio's EBT Margin stood at 41.58%, which was up 131300.0% from 48.97% recorded in Q2 2025.
  • Over the past 5 years, Bio's EBT Margin peaked at 34.1% during Q1 2024, and registered a low of 138.81% during Q1 2021.
  • Moreover, its 5-year median value for EBT Margin was 80.45% (2023), whereas its average is 83.82%.
  • As far as peak fluctuations go, Bio's EBT Margin skyrocketed by 708700bps in 2024, and later tumbled by -264400bps in 2025.
  • Bio's EBT Margin (Quarter) stood at 102.41% in 2021, then increased by 11bps to 91.32% in 2022, then rose by 12bps to 80.14% in 2023, then skyrocketed by 34bps to 52.99% in 2024, then rose by 22bps to 41.58% in 2025.
  • Its EBT Margin was 41.58% in Q3 2025, compared to 48.97% in Q2 2025 and 60.54% in Q1 2025.